Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Learn More
Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.

Learn More

RESEARCH & DEVELOPMENT

The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2021-2022. 

+
+

Press releases

January 19, 2023

LinKinVax and Gustave Roussy collaborate to conduct a Phase I/IIa HPV.DCVax clinical trial for the treatment of patients with human papillomavirus (HPV) associated oropharyngeal cancer

See press release
January 10, 2023

LinKinvax just completed a new round of financing, initiated in 2022

See press release
see more

NEWS

December 1, 2022

Pour la Journée Mondiale du Sida, Pr Yves Levy, fait le point avec Stephanie Benz de l’Express sur le potentiel de notre vaccin contre la maladie.

CLICK HERE

LinKinVax participe aux French healthcare days LATAM

CLICK HERE
June 10, 2022

Yves Levy & André-Jacques Auberton-Herve interviewés par Meriadec Gaignard

CLICK HERE

Covid : un candidat vaccin français de longue durée

PDF LINK

Nous visons cinq vaccins dans les cinq ans» contre le VIH ou le Covid-19, annoncent les fondateurs de la biotech Linkinvax (usinenouvelle.com)

CLICK HERE
June 23, 2021

LinKinvax, biotech créée pour accélérer le développement et l’entrée en essai clinique d’une plateforme vaccinale unique et innovante

CLICK HERE
see more

Interested in our project?

CONTACT US